INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

A groundbreaking discovery by scientists at Japan’s RIKEN Center for Brain Science has revealed an unexpected link between dopamine and Alzheimer’s disease. This revelation could mark a major ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

a timely and accurate diagnosis can improve patients’ chances to benefit from current treatments and participate in clinical trials. We believe accelerating the diagnosis of Alzheimer’s can ...

Kathy Ingebrand was diagnosed with Alzheimer's at 59 years old. "This patient is receiving a treatment, which is designed to clear a protein called amyloid from the brain, which is accumulating in ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... based on current information and ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

characterised by cognitive impairment and memory loss. Professor Götz said current medications target disease progression and symptoms but don't offer patients a cure. "Therapeutic ultrasound ...

According to Alzheimer’s Disease International and Dementia Forecasting Collaborators, Alzheimer’s Disease is currently the ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...